Access cutting-edge oropharyngeal carcinoma (opc) treatment through this phase 3 clinical trial at a research site in Tucson. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Tucson location
Preparing your pre-screening questions…
Access oropharyngeal carcinoma (opc) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related oropharyngeal carcinoma (opc) treatment provided free
Check if you qualify for this oropharyngeal carcinoma (opc) clinical trial in Tucson, AZ
No-Cost Study Care
Local to Tucson
Convenient for AZ residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this study is to understand whether CRB-701, a targeted form of chemotherapy called an anti-body drug conjugate, will work as a treatment for oropharyngeal (throat, tonsil) cancer. In patients who have already received platinum based chemotherapy or immunotherapy (using a check-point inhibitor) It will also learn about the safety of the drug and measure quality of life. The main questions it asks are: * What proportion of participants respond to CRB-701 measured using scans (CT or MRI) * What medical problems do participants experience when taking CRB-701. Researchers will compare CRB-701 with standard of care medicines (drugs that are normally used this disease). Participants will: * Attend clinic every three weeks to receive infusions of CRB-701 or standard of care medicines until the cancer cannot be measured or is not controlled by the treatment they are receiving. * Have a CT or MRI every 6 weeks to measure the effect on their cancer * Complete questionnaires to assess their health status.
Sponsor: Corbus Pharmaceuticals Inc.
Yes, this clinical trial (NCT07768189) has an active research site in Tucson, AZ that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for oropharyngeal carcinoma (opc) treatment options in Tucson, AZ, this clinical trial (NCT07768189) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tucson research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced oropharyngeal carcinoma (opc) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all oropharyngeal carcinoma (opc) clinical trials near you to find additional studies recruiting in your area.
See all head and neck cancer clinical trials recruiting in Tucson — not just this study.
Browse Head and Neck Cancer Trials in Tucson →